[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368733-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-368733-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","integrating-12-spatial-and-single-cell-technologies-to-characterise-tumour-neighbourhoods-and-cellular-interactions-in-three-skin-cancer-types","Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types","","Cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC), and melanoma represent over 70% of cancer cases, yet the skin cancer microenvironment is not well defined across both outer origin layers and deeper junctional/dermal progression zones. A study integrates 12 complementary spatial single-cell technologies to build orthogonally validated cell signatures, spatial maps, and interactomes for cSCC, BCC, and melanoma. Four spatial transcriptomics platforms identify keratinocyte cancer signatures with consistently validated gene markers, and multi-omics integration reveals cancer communities enriched in melanocyte–fibroblast–T-cell colocalization. Ligand-receptor analysis across extensive cell-type combinations highlights CD44, integrins, and collagens, with CD44-FGF2 as a therapeutic candidate, while interactions are validated using multiple experimental assays and supported by genetic association mapping in over 500,000 individuals.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrating-12-spatial-and-single-cell-technologies-to-characterise-tumour-neighbourhoods-and-cellular-interactions-in-three-skin-cancer-types/368733/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrating-12-spatial-and-single-cell-technologies-to-characterise-tumour-neighbourhoods-and-cellular-interactions-in-three-skin-cancer-types/368733.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"Which skin cancer types are analyzed in this study?","Question",{"text":63,"@type":64},"The study focuses on cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC), and melanoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the main methodological approach?",{"text":68,"@type":64},"It integrates 12 complementary spatial single-cell technologies to generate validated cell signatures, spatial maps, and interactomes, including orthogonal validation of signatures.",{"name":70,"@type":61,"acceptedAnswer":71},"Which molecular interactions and targets are highlighted?",{"text":72,"@type":64},"Ligand-receptor analysis emphasizes CD44, integrins, and collagens, with CD44-FGF2 identified as a potential therapeutic target.",{"name":74,"@type":61,"acceptedAnswer":75},"How are key cell–cell interactions validated and supported?",{"text":76,"@type":64},"The work validates interactions using Opal Polaris, RNAScope, and Proximal Ligation Assays, and supports population-scale relevance using genetic association mapping in over 500,000 individuals.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},368733,1790248726,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":101,"preview_urls":151},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","bioRxiv preprint doi: [https://doi.org/10.1101/2025.07.25.666708](https://doi.org/10.1101/2025.07.25.666708); this version posted July 28, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is  \nmade available under aCC-BY-ND 4.0 International license.  \nIntegrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer  \nTypes  \nP. Prakrithi 1,2\\# , Laura F. Grice 1,2,3\\# , Feng Zhang 1,2\\# , Levi Hockey1,2 , Samuel X. Tan4 , Xiao Tan 1,2 , Zherui Xiong1,2 , Onkar Mulay 1,2 , Andrew Causer1,2 , Andrew Newman 1,2 , Duy Pham 1 , Guiyan Ni 1 , Kelvin Tuong5 , Xinnan Jin 1,2 , Eunju Kim3,4 , Minh Tran 1 , Hani Vu 1,2 , Nicholas M. Muller4 , Emily E. Killingbeck6 , Mark T. Gregory6 , Siok Min Teoh 1 ,Tuan Vo 1 , Min Zhang7 , Maria Teresa Landi8 , Kevin M. Brown8 , Mark  \nM. Iles9 , Zachary Reitz6 , Katharina Devitt 10 , Liuliu Pan6 , Arutha Kulasinghe6 , Yung-Ching Kao4 , Michael Leon6 , Sarah R. Murphy6 , Hiromi Sato6 , Jazmina Gonzalez Cruz 10 , Snehlata Kumari 10 , Hung N. Luu 11 , Sarah E. Warren6 , Chris McMillan12, 13 , Joakim Henricson14,15 , Chris Anderson 14,15 , David Muller12,13 , Arun Everest-Dass 16 , Blake O’Brien 17 , Mathias Seviiri 16 , Matthew H. Law 18, 19, 20 , H. Peter Soyer4 , Ian Frazer10 , Youngmi Kim6,21 , Mitchell S. Stark4 , Kiarash Khosrotehrani4 , Quan Nguyen 1,2  \n1 QIMR Berghofer, Immunology and Infection program, Brisbane, QLD 4006, Australia  \n2 Division of Genetics and Genomics, Institute for Molecular Bioscience, The University of Queensland, QLD 4072, Australia  \n3 School of Biomedical Sciences, The University of Queensland, QLD 4072, Australia  \n4 Frazer Institute, Dermatology Research Centre, Experimental Dermatology Group, The University of Queensland, Brisbane, Australia  \n5 Ian Frazer Centre for Children’s Immunotherapy Research, Child Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia  \n6 Bruker Spatial Biology, NanoString® Technologies, Seattle WA 98109, USA  \n7 School of Agriculture and Food Sciences, The University of Queensland, QLD 4072, Australia  \n8 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA  \n9 Leeds Institute for Data Analytics, University of Leeds, Leeds, UK  \n10 Frazer Institute, The University of Queensland, Brisbane,QLD 4072, Australia  \n11 UMPC Hillman Cancer Center & School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA  \n12 School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia  \n13 Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia  \n14 Department of Emergency Medicine in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden  \n15 Department of Dermatology and venereology in Östergötland, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden  \n16 Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, QLD 4215  \n17 Sullivan Nicolaides Pathology, Bowen Hills, Qld 4006, Australia  \n18 QIMR Berghofer, Population Health program, Brisbane, QLD 4006, Australia  \n19 School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, 4001, Australia  \n20 School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, QLD, 4072, Australia  \n21 Pfizer, 21621 30th Dr SE, Bothell, WA 98021  \n\\#co-first authors  \nCorrespondence: [quan.nguyen@qimrberghofer.edu.au](quan.nguyen@qimrberghofer.edu.au)  \nbioRxiv preprint doi: [https://doi.org/10.1101/2025.07.25.666708](https://doi.org/10.1101/2025.07.25.666708); this version posted","cbCaifuSLjqX335K","https://ap.wps.com/l/cbCaifuSLjqX335K","pdf",8430096,46,"English","# Abstract\n## Spatial technologies integration and cell signatures\n## Omics integration and cancer communities\n## Ligand-receptor interactions and therapeutic targets\n## Experimental validation and genetic association mapping","[{\"question\":\"Which skin cancer types are analyzed in this study?\",\"answer\":\"The study focuses on cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC), and melanoma.\"},{\"question\":\"What is the main methodological approach?\",\"answer\":\"It integrates 12 complementary spatial single-cell technologies to generate validated cell signatures, spatial maps, and interactomes, including orthogonal validation of signatures.\"},{\"question\":\"Which molecular interactions and targets are highlighted?\",\"answer\":\"Ligand-receptor analysis emphasizes CD44, integrins, and collagens, with CD44-FGF2 identified as a potential therapeutic target.\"},{\"question\":\"How are key cell–cell interactions validated and supported?\",\"answer\":\"The work validates interactions using Opal Polaris, RNAScope, and Proximal Ligation Assays, and supports population-scale relevance using genetic association mapping in over 500,000 individuals.\"}]","Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types | PDF",1790178253,116,[152,156,160,164,168],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7340d10ecd5eafc304aacfad144ef06.webp",983,1388,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb3ba002bea23024cc02b64d028eb198.webp",982,1387,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67833645c34edd26d96c067e00d11bbd.webp",981,1385,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c23ff4ef5bcc24096369e06b7c99ee19.webp",980,1384,{"page_no":101,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7213f31a4dc6205e7244c940a300d01.webp",979,1382]